Senorics GmbH wins new investor, raises more than 8 million EUR in funding to expand material sensing technology and its commercialization

/

Oberkochen, Germany | ZEISS Group

The ZEISS Ventures Portfolio startup Senorics GmbH, a high-tech spin-off from the University of Technology Dresden (TU Dresden) successfully closed a new financing round.

Senorics is specialized in designing and manufacturing optical spectroscopic sensor solutions for mass market applications to make material sensing easy and affordable. Responding to the process industry’s soaring need for immediate workflow optimization, Senorics will use the new funds to accelerate the roll-out of its innovative near infrared (NIR)-spectroscopy sensors based on organic semiconductor technology.

In 2019 ZEISS and Senorics entered a technological cooperation to further develop the technology and to identify new application fields which laid the foundation for the current investment by ZEISS Ventures.
“In a highly automated world, the need to meet high-quality standards, to develop compact, low-cost solutions such as the one developed by Senorics plays an important role to address new applications in material sensing,” says Gerrit Schulte Head of ZEISS Ventures.

The new investment round is led by the FIDURA Private Equity Fonds, a shareholder of various growth stage companies, holding an active portfolio of technology investments. They are joined in the round by all existing investors such as TGFS (Technologiegründerfonds Sachsen) and a public funding by the Development Bank of Saxony (Sächsische Aufbaubank).

“With these powerful new partner and investments, we will be able to commercialize our solution in the initial target application fields and further develop our patented optical sensor technology,” explains Dr. Ronny Timmreck Founder and CEO of Senorics.

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 6.3 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2020).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 12 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 34,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG (status: 31 March 2021).

Further information at www.zeiss.com

 

< | >